FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jean Rivier

Research Profile

Living Beings

Chemicals & Drugs

Genes & Molecular Sequences

Amino Acid Sequences

Concepts & Ideas

Physiology

Gastric Emptying

Anatomy

Co-author Network

Publications

TOP 3
Andreas Stengel; Jean Rivier; Yvette Taché
Modulation of the adaptive response to stress by brain activation of selective somatostatin receptor subtypes.
Xuejuan Wang; Melpomeni Fani; Jean Claude Reubi; Jean Rivier; Stefan Schulz; Helmut R Maecke
Comprehensive evaluation of a somatostatin-based radiolabelled antagonist for diagnostic imaging and radionuclide therapy.
Andreas Stengel; Lixin Wang; Miriam Goebel-Stengel; Nils W G Lambrecht; Jean Rivier; Almaas Shaikh; Yvette Taché
Abdominal surgery inhibits circulating acyl ghrelin and ghrelin-O-acyltransferase levels in rats: role of the somatostatin receptor subtype 2.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jean Rivier (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Andreas Stengel; Jean Rivier; Yvette Taché
Modulation of the adaptive response to stress by brain activation of selective somatostatin receptor subtypes.
Peptides 2013;42():70-7.
2012: Xuejuan Wang; Melpomeni Fani; Jean Claude Reubi; Jean Rivier; Stefan Schulz; Helmut R Maecke
Comprehensive evaluation of a somatostatin-based radiolabelled antagonist for diagnostic imaging and radionuclide therapy.
European journal of nuclear medicine and molecular imaging 2012;39(12):1876-85.
2011: Andreas Stengel; Lixin Wang; Miriam Goebel-Stengel; Nils W G Lambrecht; Jean Rivier; Almaas Shaikh; Yvette Taché
Abdominal surgery inhibits circulating acyl ghrelin and ghrelin-O-acyltransferase levels in rats: role of the somatostatin receptor subtype 2.
American journal of physiology. Gastrointestinal and liver physiology 2011;301(2):G239-48.
2011: A Stengel; Lixin Wang; M Goebel-Stengel; E Hu; A Luckey; Jean Rivier; Yvette Taché
Central administration of pan-somatostatin agonist ODT8-SST prevents abdominal surgery-induced inhibition of circulating ghrelin, food intake and gastric emptying in rats.
Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 2011;23(7):e294-308.
2011: A Stengel; M Goebel-Stengel; Lixin Wang; M Larauche; Jean Rivier; Yvette Taché
Central somatostatin receptor 1 activation reverses acute stress-related alterations of gastric and colonic motor function in mice.
Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 2011;23(6):e223-36.
2011: Guillaume Gourcerol; S Vincent Wu; Pu-Qing Yuan; Hung Pham; Marcel Miampamba; Muriel Larauche; Paul Sanders; Tomofumi Amano; Agata Mulak; Eunok Im; Charalabos Pothoulakis; Jean Rivier; Yvette Taché; Mulugeta Million
Activation of corticotropin-releasing factor receptor 2 mediates the colonic motor coping response to acute stress in rodents.
Gastroenterology 2011;140(5):1586-96.e6.
2011: Andreas Stengel; Tamer Coskun; Miriam Goebel-Stengel; Libbey Craft; Jorge Alsina-Fernandez; Lixin Wang; Jean Rivier; Yvette Taché
Chronic injection of pansomatostatin agonist ODT8-SST differentially modulates food intake and decreases body weight gain in lean and diet-induced obese rats.
Regulatory peptides 2011;167(2-3):201-8.
2010: Andreas Stengel; Miriam Goebel; Lixin Wang; Jean Rivier; Peter Kobelt; Hubert Mönnikes; Yvette Taché
Activation of brain somatostatin 2 receptors stimulates feeding in mice: analysis of food intake microstructure.
Physiology & behavior 2010;101(5):614-22.
2010: Andreas Stengel; Tamer Coskun; Miriam Goebel; Lixin Wang; Libbey Craft; Jorge Alsina-Fernandez; Jean Rivier; Yvette Taché
Central injection of the stable somatostatin analog ODT8-SST induces a somatostatin2 receptor-mediated orexigenic effect: role of neuropeptide Y and opioid signaling pathways in rats.
Endocrinology 2010;151(9):4224-35.
2010: A Stengel; M Goebel; Lixin Wang; Jean Rivier; P Kobelt; H Monnikes; Y Tache
Selective central activation of somatostatin receptor 2 increases food intake, grooming behavior and rectal temperature in rats.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2010;61(4):399-407.
2009: Andreas Stengel; Miriam Goebel; Lixin Wang; Jean Rivier; Peter Kobelt; Hubert Mönnikes; Nils W G Lambrecht; Yvette Taché
Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor2 receptor.
Endocrinology 2009;150(11):4911-9.
2009: Thomas Dieterle; Silvia Meili-Butz; Katrin Bühler; Christian Morandi; Dietlinde John; Peter T Buser; Jean Rivier; Wylie W Vale; Kirk L Peterson; Marijke Brink
Immediate and sustained blood pressure lowering by urocortin 2: a novel approach to antihypertensive therapy?
Hypertension 2009;53(4):739-44.
2008: Mark Huising; Joan M Vaughan; Shaili H Shah; Katherine L Grillot; Cynthia J Donaldson; Jean Rivier; Gert Flik; Wylie W Vale
Residues of corticotropin releasing factor-binding protein (CRF-BP) that selectively abrogate binding to CRF but not to urocortin 1.
The Journal of biological chemistry 2008;283(14):8902-12.
2007: Pu-Qing Yuan; Mulugeta Million; S Vincent Wu; Jean Rivier; Yvette Taché
Peripheral corticotropin releasing factor (CRF) and a novel CRF1 receptor agonist, stressin1-A activate CRF1 receptor expressing cholinergic and nitrergic myenteric neurons selectively in the colon of conscious rats.
Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 2007;19(11):923-36.
2007: Christy Rani R Grace; Laura Cervini; Jozsef Gulyas; Jean Rivier; Roland Riek
Astressin-amide and astressin-acid are structurally different in dimethylsulfoxide.
Biopolymers 2007;87(2-3):196-205.
2007: Paul Whiteaker; Sean Christensen; Doju Yoshikami; Cheryl Dowell; Maren Watkins; Jozsef Gulyas; Jean Rivier; Baldomero M Olivera; J Michael McIntosh
Discovery, synthesis, and structure activity of a highly selective alpha7 nicotinic acetylcholine receptor antagonist.
Biochemistry 2007;46(22):6628-38.
2007: Manoj P Samant; Richard White; Doley J Hong; Glenn Croston; P Michael Conn; Jo Ann Janovick; Jean Rivier
Structure-activity relationship studies of gonadotropin-releasing hormone antagonists containing S-aryl/alkyl norcysteines and their oxidized derivatives.
Journal of medicinal chemistry 2007;50(9):2067-77.
2007: Jean Rivier; Jozsef Gulyas; Koichi S Kunitake; Michael R DiGruccio; Jeffrey P Cantle; Marilyn H Perrin; Cynthia J Donaldson; Joan Vaughan; Mulugeta Million; Guillaume Gourcerol; David W Adelson; Catherine Rivier; Yvette Taché; Wylie Vale
Stressin1-A, a potent corticotropin releasing factor receptor 1 (CRF1)-selective peptide agonist.
Journal of medicinal chemistry 2007;50(7):1668-74.
2007: Mulugeta Million; Lixin Wang; Mary P Stenzel-Poore; Sarah C Coste; Pu-Qing Yuan; C Lamy; Jean Rivier; T Buffington; Yvette Taché
Enhanced pelvic responses to stressors in female CRF-overexpressing mice.
American journal of physiology. Regulatory, integrative and comparative physiology 2007;292(4):R1429-38.
2006: Beatrice Waser; Ruth Rehmann; Jean Rivier; Wylie Vale; Jean Claude Reubi
CRF receptors in the rodent and human cardiovascular systems: species differences.
Peptides 2006;27(12):3029-38.
2006: Guillaume Gourcerol; Mulugeta Million; David W Adelson; Y Wang; Lixin Wang; Jean Rivier; D H St-Pierre; Yvette Taché
Lack of interaction between peripheral injection of CCK and obestatin in the regulation of gastric satiety signaling in rodents.
Peptides 2006;27(11):2811-9.
2006: Mihaela Ginj; Hanwen Zhang; Beatrice Waser; Renzo Cescato; Damian Wild; Xuejuan Wang; Judit Erchegyi; Jean Rivier; Helmut R Mäcke; Jean Claude Reubi
Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(44):16436-41.
2006: Christy Rani R Grace; Judit Erchegyi; Steven C Koerber; Jean Claude Reubi; Jean Rivier; Roland Riek
Novel sst2-selective somatostatin agonists. Three-dimensional consensus structure by NMR.
Journal of medicinal chemistry 2006;49(15):4487-96.
2006: Manoj P Samant; Doley J Hong; Glenn Croston; Catherine Rivier; Jean Rivier
Novel analogues of degarelix incorporating hydroxy-, methoxy-, and pegylated-urea moieties at positions 3, 5, 6 and the N-terminus. Part III.
Journal of medicinal chemistry 2006;49(12):3536-43.
2006: Alfredo Leaños-Miranda; Alfredo Ulloa-Aguirre; Laura Cervini; Jo Ann Janovick; Jean Rivier; P Michael Conn
Identification of new gonadotrophin-releasing hormone partial agonists.
The Journal of endocrinology 2006;189(3):509-17.
2006: Mulugeta Million; Lixin Wang; Y Wang; David W Adelson; Pu-Qing Yuan; Céline Maillot; Santosh V Coutinho; James A McRoberts; Alfred Bayati; Hillevi Mattsson; VS Wu; JY Wei; Jean Rivier; Wylie Vale; Emeran Mayer; Yvette Taché
CRF2 receptor activation prevents colorectal distension induced visceral pain and spinal ERK1/2 phosphorylation in rats.
Gut 2006;55(2):172-81.
2006: Russell W Teichert; Estuardo López-Vera; Jozsef Gulyas; Maren Watkins; Jean Rivier; Baldomero M Olivera
Definition and characterization of the short alphaA-conotoxins: a single residue determines dissociation kinetics from the fetal muscle nicotinic acetylcholine receptor.
Biochemistry 2006;45(4):1304-12.
2005: Manoj P Samant; Jozsef Gulyas; Doley J Hong; Glenn Croston; Catherine Rivier; Jean Rivier
Iterative approach to the discovery of novel degarelix analogues: substitutions at positions 3, 7, and 8. Part II.
Journal of medicinal chemistry 2005;48(15):4851-60.
2005: Mulugeta Million; Céline Maillot; David A Adelson; Tsukasa Nozu; Ariane Gauthier; Jean Rivier; George Chrousos; Alfred Bayati; Hillevi Mattsson; Yvette Taché
Peripheral injection of sauvagine prevents repeated colorectal distension-induced visceral pain in female rats.
Peptides 2005;26(7):1188-95.
2005: Qisheng Liu; Renzo Cescato; Dian A Dewi; Jean Rivier; Jean Claude Reubi; Agnes Schonbrunn
Receptor signaling and endocytosis are differentially regulated by somatostatin analogs.
Molecular pharmacology 2005;68(1):90-101.
2005: Gloria P Corpuz; Richard B Jacobsen; Elsie C Jimenez; Maren Watkins; Craig Walker; Clark Colledge; James E Garrett; Owen McDougal; Wenqin Li; William R Gray; David R Hillyard; Jean Rivier; J Michael McIntosh; Lourdes J Cruz; Baldomero M Olivera
Definition of the M-conotoxin superfamily: characterization of novel peptides from molluscivorous Conus venoms.
Biochemistry 2005;44(22):8176-86.
2005: Manoj P Samant; Jozsef Gulyas; Doley J Hong; Glenn Croston; Catherine Rivier; Jean Rivier
Synthesis, in vivo and in vitro biological activity of novel azaline B analogs.
Bioorganic & medicinal chemistry letters 2005;15(11):2894-7.
2005: Russell W Teichert; Jean Rivier; Josep Torres; John Dykert; Charleen Miller; Baldomero M Olivera
A uniquely selective inhibitor of the mammalian fetal neuromuscular nicotinic acetylcholine receptor.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2005;25(3):732-6.
2005: Manoj P Samant; Doley J Hong; Glenn Croston; Catherine Rivier; Jean Rivier
Novel gonadotropin-releasing hormone antagonists with substitutions at position 5.
Biopolymers 2005;80(2-3):386-91.
2004: Sean M Smith; Joan M Vaughan; Cynthia J Donaldson; Jean Rivier; Chien Li; Alon Chen; Wylie W Vale
Cocaine- and amphetamine-regulated transcript activates the hypothalamic-pituitary-adrenal axis through a corticotropin-releasing factor receptor-dependent mechanism.
Endocrinology 2004;145(11):5202-9.
2004: Vicente Martinez; Lixin Wang; Mulugeta Million; Jean Rivier; Yvette Taché
Urocortins and the regulation of gastrointestinal motor function and visceral pain.
Peptides 2004;25(10):1733-44.
2004: Russell W Teichert; Jean Rivier; John Dykert; Laura Cervini; Jozsef Gulyas; Grzegorz Bulaj; Michael Ellison; Baldomero M Olivera
AlphaA-Conotoxin OIVA defines a new alphaA-conotoxin subfamily of nicotinic acetylcholine receptor inhibitors.
Toxicon : official journal of the International Society on Toxinology 2004;44(2):207-14.
2004: Vicente Martínez; Lixin Wang; Jean Rivier; Dimitri E Grigoriadis; Yvette Taché
Central CRF, urocortins and stress increase colonic transit via CRF1 receptors while activation of CRF2 receptors delays gastric transit in mice.
The Journal of physiology 2004;556(Pt 1):221-34.
2004: Tracy L Bale; Masahiko Hoshijima; Yusu Gu; Nancy Dalton; Keith R Anderson; Kuo-Fen Lee; Jean Rivier; Kenneth R Chien; Wylie W Vale; Kirk L Peterson
The cardiovascular physiologic actions of urocortin II: acute effects in murine heart failure.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(10):3697-702.
2003: Christy Rani R Grace; Steven C Koerber; Judit Erchegyi; Jean Claude Reubi; Jean Rivier; Roland Riek
Novel sst(4)-selective somatostatin (SRIF) agonists. 4. Three-dimensional consensus structure by NMR.
Journal of medicinal chemistry 2003;46(26):5606-18.
2003: Judit Erchegyi; Beatrice Waser; Jean-Claude Schaer; Renzo Cescato; Jean François Brazeau; Jean Rivier; Jean Claude Reubi
Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
Journal of medicinal chemistry 2003;46(26):5597-605.
2003: Judit Erchegyi; Botond Penke; Lajos Simon; Scott Michaelson; Sandra Wenger; Beatrice Waser; Renzo Cescato; Jean-Claude Schaer; Jean Claude Reubi; Jean Rivier
Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.
Journal of medicinal chemistry 2003;46(26):5587-96.
2003: Jean Rivier; Judit Erchegyi; Carl A Hoeger; Charleen Miller; William Low; Sandra Wenger; Beatrice Waser; Jean-Claude Schaer; Jean Claude Reubi
Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan.
Journal of medicinal chemistry 2003;46(26):5579-86.
2003: Glenn R Valdez; Eric P Zorrilla; Jean Rivier; Wylie W Vale; George F Koob
Locomotor suppressive and anxiolytic-like effects of urocortin 3, a highly selective type 2 corticotropin-releasing factor agonist.
Brain research 2003;980(2):206-12.
2003: Jean Claude Reubi; Beatrice Waser; Wylie Vale; Jean Rivier
Expression of CRF1 and CRF2 receptors in human cancers.
The Journal of clinical endocrinology and metabolism 2003;88(7):3312-20.
2003: Chien Li; Peilin Chen; Joan Vaughan; Amy L Blount; Alon Chen; Pauline M Jamieson; Jean Rivier; M Susan Smith; Wylie Vale
Urocortin III is expressed in pancreatic beta-cells and stimulates insulin and glucagon secretion.
Endocrinology 2003;144(7):3216-24.
2003: Elsie C Jimenez; Reshma P Shetty; Marcelina Lirazan; Jean Rivier; Craig Walker; Fe C Abogadie; Doju Yoshikami; Lourdes J Cruz; Baldomero M Olivera
Novel excitatory Conus peptides define a new conotoxin superfamily.
Journal of neurochemistry 2003;85(3):610-21.
2003: Koki Inoue; Glenn R Valdez; Teresa Reyes; Lindsay E Reinhardt; Antoine Tabarin; Jean Rivier; Wylie W Vale; Paul E Sawchenko; George F Koob; Eric P Zorrilla
Human urocortin II, a selective agonist for the type 2 corticotropin-releasing factor receptor, decreases feeding and drinking in the rat.
The Journal of pharmacology and experimental therapeutics 2003;305(1):385-93.
2002: Jean Rivier; Jozsef Gulyas; D Kirby; William Low; Marilyn H Perrin; Koichi S Kunitake; Michael R DiGruccio; Joan Vaughan; Jean Claude Reubi; Beatrice Waser; Steven C Koerber; Vicente Martinez; L Wang; Yvette Taché; Wylie Vale
Potent and long-acting corticotropin releasing factor (CRF) receptor 2 selective peptide competitive antagonists.
Journal of medicinal chemistry 2002;45(21):4737-47.
2002: Suraj Unniappan; Xinwei Lin; Laura Cervini; Jean Rivier; Hiroyuki Kaiya; Kenji Kangawa; Richard E Peter
Goldfish ghrelin: molecular characterization of the complementary deoxyribonucleic acid, partial gene structure and evidence for its stimulatory role in food intake.
Endocrinology 2002;143(10):4143-6.
2002: Glenn R Valdez; Koki Inoue; George F Koob; Jean Rivier; Wylie Vale; Eric P Zorrilla
Human urocortin II: mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide.
Brain research 2002;943(1):142-50.
2002: C-Y Chen; Mulugeta Million; David W Adelson; Vicente Martínez; Jean Rivier; Yvette Taché
Intracisternal urocortin inhibits vagally stimulated gastric motility in rats: role of CRF(2).
British journal of pharmacology 2002;136(2):237-47.
2002: Xinwei Lin; Caroline Nunn; Daniel Hoyer; Jean Rivier; Richard E Peter
Identification and characterization of a type five-like somatostatin receptor in goldfish pituitary.
Molecular and cellular endocrinology 2002;189(1-2):105-16.
2002: Mulugeta Million; Céline Maillot; Paul Saunders; Jean Rivier; Wylie Vale; Yvette Taché
Human urocortin II, a new CRF-related peptide, displays selective CRF(2)-mediated action on gastric transit in rats.
American journal of physiology. Gastrointestinal and liver physiology 2002;282(1):G34-40.
2001: Kathy Lewis; Chien Li; Marilyn H Perrin; Amy L Blount; Koichi S Kunitake; Cynthia J Donaldson; Joan Vaughan; Teresa Reyes; Jozsef Gulyas; W Fischer; Louise M Bilezikjian; Jean Rivier; Paul E Sawchenko; Wylie W Vale
Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(13):7570-5.
2001: Teresa Reyes; Kathy Lewis; Marilyn H Perrin; Koichi S Kunitake; Joan Vaughan; C A Arias; John B Hogenesch; Jozsef Gulyas; Jean Rivier; Wylie W Vale; Paul E Sawchenko
Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(5):2843-8.
2000: Jean Claude Reubi; Jean-Claude Schaer; Sandra Wenger; Carl A Hoeger; Judit Erchegyi; Beatrice Waser; Jean Rivier
SST3-selective potent peptidic somatostatin receptor antagonists.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(25):13973-8.
2000: V Martínez; Jean Rivier; D Coy; Yvette Taché
Intracisternal injection of somatostatin receptor 5-preferring agonists induces a vagal cholinergic stimulation of gastric emptying in rats.
The Journal of pharmacology and experimental therapeutics 2000;293(3):1099-105.
2000: Anne R Albers; M Sue O'Dorisio; Douglas A Balster; MG Caprara; P Gosh; F Chen; Carl A Hoeger; Jean Rivier; Gail D Wenger; Thomas M O'Dorisio; Stephen J Qualman
Somatostatin receptor gene expression in neuroblastoma.
Regulatory peptides 2000;88(1-3):61-73.
1999: L Chen; Carl A Hoeger; Jean Rivier; VD Fitzpatrick; RL Vandlen; Armen H Tashjian
Structural basis for the binding specificity of a SSTR1-selective analog of somatostatin.
Biochemical and biophysical research communications 1999;258(3):689-94.
1999: Laura Cervini; P Theobald; Anne Z Corrigan; A Grey Craig; Catherine Rivier; Wylie Vale; Jean Rivier
Corticotropin releasing factor (CRF) agonists with reduced amide bonds and Ser7 substitutions.
Journal of medicinal chemistry 1999;42(4):761-8.
1998: Jean Rivier; Jozsef Gulyas; Anne Z Corrigan; Vicente Martinez; A Grey Craig; Yvette Taché; Wylie Vale; Catherine Rivier
Astressin analogues (corticotropin-releasing factor antagonists) with extended duration of action in the rat.
Journal of medicinal chemistry 1998;41(25):5012-9.
1998: Steven C Koerber; Jozsef Gulyas; SL Lahrichi; Anne Z Corrigan; A Grey Craig; Catherine Rivier; Wylie Vale; Jean Rivier
Constrained corticotropin-releasing factor (CRF) agonists and antagonists with i-(i+3) Glu-Xaa-DXbb-Lys bridges.
Journal of medicinal chemistry 1998;41(25):5002-11.
1998: Lucinda England; Julita S Imperial; Richard B Jacobsen; A Grey Craig; Jozsef Gulyas; M Akhtar; Jean Rivier; David Julius; Baldomero M Olivera
Inactivation of a serotonin-gated ion channel by a polypeptide toxin from marine snails.
Science (New York, N.Y.) 1998;281(5376):575-8.
1998: Jean Rivier; SL Lahrichi; Jozsef Gulyas; Judit Erchegyi; Steven C Koerber; A Grey Craig; Anne Z Corrigan; Catherine Rivier; Wylie Vale
Minimal-size, constrained corticotropin-releasing factor agonists with i-(i+3) Glu-Lys and Lys-Glu bridges.
Journal of medicinal chemistry 1998;41(14):2614-20.
1998: Jean Claude Reubi; Jean-Claude Schaer; Beatrice Waser; Carl A Hoeger; Jean Rivier
A selective analog for the somatostatin sst1-receptor subtype expressed by human tumors.
European journal of pharmacology 1998;345(1):103-10.
1997: A Miranda; SL Lahrichi; Jozsef Gulyas; Steven C Koerber; A Grey Craig; Anne Z Corrigan; Catherine Rivier; Wylie Vale; Jean Rivier
Constrained corticotropin-releasing factor antagonists with i-(i + 3) Glu-Lys bridges.
Journal of medicinal chemistry 1997;40(22):3651-8.
1997: KJ Shon; M Grilley; Richard B Jacobsen; George Cartier; C Hopkins; William R Gray; Maren Watkins; David R Hillyard; Jean Rivier; Josep Torres; Doju Yoshikami; Baldomero M Olivera
A noncompetitive peptide inhibitor of the nicotinic acetylcholine receptor from Conus purpurascens venom.
Biochemistry 1997;36(31):9581-7.
1997: KH Han; K J Hwang; S M Kim; S K Kim; William R Gray; Baldomero M Olivera; Jean Rivier; KJ Shon
NMR structure determination of a novel conotoxin, [Pro 7,13] alpha A-conotoxin PIVA.
Biochemistry 1997;36(7):1669-77.
1996: Jean Rivier; G C Jiang; SL Lahrichi; J Porter; Steven C Koerber; Josep Rizo; Anne Z Corrigan; L Gierasch; A Hagler; Wylie Vale; Catherine Rivier
Dose relationship between GnRH antagonists and pituitary suppression.
Human reproduction (Oxford, England) 1996;11 Suppl 3():133-47.
1996: Catherine Rivier; Jean Rivier; Soon Lee
Importance of pituitary and brain receptors for corticotrophin-releasing factor in modulating alcohol-induced ACTH secretion in the rat.
Brain research 1996;721(1-2):83-90.
1995: Jozsef Gulyas; Catherine Rivier; M Perrin; Steven C Koerber; S Sutton; Anne Z Corrigan; SL Lahrichi; A Grey Craig; Wylie Vale; Jean Rivier
Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(23):10575-9.
1995: C Hopkins; M Grilley; C Miller; KJ Shon; Lourdes J Cruz; William R Gray; John Dykert; Jean Rivier; Doju Yoshikami; Baldomero M Olivera
A new family of Conus peptides targeted to the nicotinic acetylcholine receptor.
The Journal of biological chemistry 1995;270(38):22361-7.
1995: S W Sutton; D P Behan; SL Lahrichi; R Kaiser; Anne Z Corrigan; P Lowry; E Potter; Marilyn H Perrin; Jean Rivier; Wylie W Vale
Ligand requirements of the human corticotropin-releasing factor-binding protein.
Endocrinology 1995;136(3):1097-102.
1994: A Miranda; Steven C Koerber; Jozsef Gulyas; SL Lahrichi; A Grey Craig; Anne Z Corrigan; A Hagler; Catherine Rivier; Wylie Vale; Jean Rivier
Conformationally restricted competitive antagonists of human/rat corticotropin-releasing factor.
Journal of medicinal chemistry 1994;37(10):1450-9.
1993: J F Hernandez; W Kornreich; Catherine Rivier; A Miranda; G Yamamoto; J Andrews; Y Taché; Wylie Vale; Jean Rivier
Synthesis and relative potencies of new constrained CRF antagonists.
Journal of medicinal chemistry 1993;36(20):2860-7.
1993: Jean Rivier; Catherine Rivier; R Galyean; A Miranda; C Miller; A Grey Craig; G Yamamoto; M Brown; Wylie Vale
Single point D-substituted corticotropin-releasing factor analogues: effects on potency and physicochemical characteristics.
Journal of medicinal chemistry 1993;36(20):2851-9.
1993: L M Kettel; Ana Alvarez Murphy; AJ Morales; Jean Rivier; W Vale; Samuel S C Yen
Rapid regression of uterine leiomyomas in response to daily administration of gonadotropin-releasing hormone antagonist.
Fertility and sterility 1993;60(4):642-6.
1993: Marilyn H Perrin; Louise M Bilezikjian; C Hoeger; Cynthia J Donaldson; Jean Rivier; Y Haas; Wylie W Vale
Molecular and functional characterization of GnRH receptors cloned from rat pituitary and a mouse pituitary tumor cell line.
Biochemical and biophysical research communications 1993;191(3):1139-44.
1993: David Feifel; Franco J Vaccarino; Jean Rivier; W W Vale
Evidence for a common neural mechanism mediating growth hormone-releasing factor-induced and somatostatin-induced feeding.
Neuroendocrinology 1993;57(2):299-305.
1992: Jean Rivier; J Porter; C Hoeger; P Theobald; A Grey Craig; John Dykert; Anne Z Corrigan; M Perrin; W A Hook; R P Siraganian
Gonadotropin-releasing hormone antagonists with N omega-triazolylornithine, -lysine, or -p-aminophenylalanine residues at positions 5 and 6.
Journal of medicinal chemistry 1992;35(23):4270-8.
1992: J M Vaughan; Jean Rivier; J Spiess; C Peng; J P Chang; Richard E Peter; Wylie Vale
Isolation and characterization of hypothalamic growth-hormone releasing factor from common carp, Cyprinus carpio.
Neuroendocrinology 1992;56(4):539-49.
1992: W D Kornreich; R Galyean; J F Hernandez; A Grey Craig; Cynthia J Donaldson; G Yamamoto; Catherine Rivier; Wylie Vale; Jean Rivier
Alanine series of ovine corticotropin releasing factor (oCRF): a structure-activity relationship study.
Journal of medicinal chemistry 1992;35(10):1870-6.
1991: R Allen; J Boublik; R L Hauger; N Scott; Jean Rivier; M R Brown
Neuropeptide Y radio-immunoassay: characterization and application.
Clinical and experimental pharmacology & physiology 1991;18(12):825-33.
1991: Baldomero M Olivera; Jean Rivier; jamie scott; David R Hillyard; Lourdes J Cruz
Conotoxins.
The Journal of biological chemistry 1991;266(33):22067-70.
1991: L M Kettel; S J Roseff; T C Chiu; M L Bangah; W Vale; Jean Rivier; H G Burger; Samuel S C Yen
Follicular arrest during the midfollicular phase of the menstrual cycle: a gonadotropin-releasing hormone antagonist imposed follicular-follicular transition.
The Journal of clinical endocrinology and metabolism 1991;73(3):644-9.
1991: P Theobald; J Porter; Catherine Rivier; Anne Z Corrigan; W Hook; R Siraganian; M Perrin; Wylie Vale; Jean Rivier
Novel gonadotropin-releasing hormone antagonists: peptides incorporating modified N omega-cyanoguanidino moieties.
Journal of medicinal chemistry 1991;34(8):2395-402.
1991: Jean Rivier; P Theobald; J Porter; M Perrin; J Gunnet; D W Hahn; Catherine Rivier
Gonadotropin releasing hormone antagonists: novel structures incorporating N omega-cyano modified guanidine moieties.
Biochemical and biophysical research communications 1991;176(1):406-12.
1990: S J Roseff; L M Kettel; Jean Rivier; H G Burger; Etienne Baulieu; Samuel S C Yen
Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women.
Fertility and sterility 1990;54(5):805-10.
1990: E E Mena; M F Gullak; M J Pagnozzi; K E Richter; Jean Rivier; Lourdes J Cruz; Baldomero M Olivera
Conantokin-G: a novel peptide antagonist to the N-methyl-D-aspartic acid (NMDA) receptor.
Neuroscience letters 1990;118(2):241-4.
1990: Baldomero M Olivera; Jean Rivier; C Clark; C A Ramilo; G P Corpuz; F C Abogadie; E E Mena; S R Woodward; David R Hillyard; Lourdes J Cruz
Diversity of Conus neuropeptides.
Science (New York, N.Y.) 1990;249(4966):257-63.
1990: J A Haack; Jean Rivier; Thomas N Parks; E E Mena; Lourdes J Cruz; Baldomero M Olivera
Conantokin-T. A gamma-carboxyglutamate containing peptide with N-methyl-d-aspartate antagonist activity.
The Journal of biological chemistry 1990;265(11):6025-9.
1989: S J Roseff; M L Bangah; L M Kettel; W Vale; Jean Rivier; H G Burger; Samuel S C Yen
Dynamic changes in circulating inhibin levels during the luteal-follicular transition of the human menstrual cycle.
The Journal of clinical endocrinology and metabolism 1989;69(5):1033-9.
1989: J M Vaughan; Wolfgang H Fischer; C Hoeger; Jean Rivier; Wylie Vale
Characterization of melanin-concentrating hormone from rat hypothalamus.
Endocrinology 1989;125(3):1660-5.
1989: J F Mortola; M Sathanandan; S Pavlou; K D Dahl; Aaron J W Hsueh; Jean Rivier; W Vale; Samuel S C Yen
Suppression of bioactive and immunoreactive follicle-stimulating hormone and luteinizing hormone levels by a potent gonadotropin-releasing hormone antagonist: pharmacodynamic studies.
Fertility and sterility 1989;51(6):957-63.
1989: Lourdes J Cruz; G Kupryszewski; G W LeCheminant; William R Gray; Baldomero M Olivera; Jean Rivier
mu-conotoxin GIIIA, a peptide ligand for muscle sodium channels: chemical synthesis, radiolabeling, and receptor characterization.
Biochemistry 1989;28(8):3437-42.
1989: Marilyn H Perrin; Y Haas; J Porter; Jean Rivier; Wylie Vale
The gonadotropin-releasing hormone pituitary receptor interacts with a guanosine triphosphate-binding protein: differential effects of guanyl nucleotides on agonist and antagonist binding.
Endocrinology 1989;124(2):798-804.
1989: J M Vaughan; Jean Rivier; Anne Z Corrigan; Richard McClintock; C A Campen; D Jolley; J K Voglmayr; C W Bardin; C Rivier; Wylie Vale
Detection and purification of inhibin using antisera generated against synthetic peptide fragments.
Methods in enzymology 1989;168():588-617.
1989: J Boublik; N Scott; J Taulane; M Goodman; M Brown; Jean Rivier
Neuropeptide Y and neuropeptide Y18-36. Structural and biological characterization.
International journal of peptide and protein research 1989;33(1):11-5.
1989: V Roberts; H Meunier; Joan Vaughan; Jean Rivier; Catherine Rivier; Wylie Vale; Paul E Sawchenko
Production and regulation of inhibin subunits in pituitary gonadotropes.
Endocrinology 1989;124(1):552-4.
1988: Paul E Sawchenko; Paul M Plotsky; S W Pfeiffer; E T Cunningham; Joan Vaughan; Jean Rivier; Wylie Vale
Inhibin beta in central neural pathways involved in the control of oxytocin secretion.
Nature 1988;334(6183):615-7.
1988: M Boyle; G Yamamoto; M Chen; Jean Rivier; Wylie Vale
Interleukin 1 prevents loss of corticotropic responsiveness to beta-adrenergic stimulation in vitro.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(15):5556-60.
1988: Jean Rivier; G Kupryszewski; J Varga; J Porter; Catherine Rivier; M Perrin; A Hagler; S Struthers; Anne Z Corrigan; Wylie Vale
Design of potent cyclic gonadotropin releasing hormone antagonists.
Journal of medicinal chemistry 1988;31(3):677-82.
1988: B Kessel; K D Dahl; R R Kazer; C H Liu; Jean Rivier; Wylie Vale; Aaron J W Hsueh; Samuel S C Yen
The dependency of bioactive follicle-stimulating hormone secretion on gonadotropin-releasing hormone in hypogonadal and cycling women.
The Journal of clinical endocrinology and metabolism 1988;66(2):361-6.
1988: Jean Rivier; Catherine Rivier; R Galyean; G Yammamoto; Wylie Vale
Potent long-acting growth hormone releasing factor analogues.
Annals of the New York Academy of Sciences 1988;527():44-50.
1987: Jean Rivier; R Galyean; L Simon; Lourdes J Cruz; Baldomero M Olivera; William R Gray
Total synthesis and further characterization of the gamma-carboxyglutamate-containing "sleeper" peptide from Conus geographus venom.
Biochemistry 1987;26(26):8508-12.
1987: J Schwartz; B Penke; Jean Rivier; Wylie Vale
A new cytotoxin specific for the target cells of corticotropin-releasing factor.
Endocrinology 1987;121(4):1454-60.
1987: J Porter; John Dykert; Jean Rivier
Synthesis, resolution and characterization of ring substituted phenylalanines and tryptophans.
International journal of peptide and protein research 1987;30(1):13-21.
1987: Jean Rivier; R Galyean; William R Gray; A Azimi-Zonooz; J Michael McIntosh; Lourdes J Cruz; Baldomero M Olivera
Neuronal calcium channel inhibitors. Synthesis of omega-conotoxin GVIA and effects on 45Ca uptake by synaptosomes.
The Journal of biological chemistry 1987;262(3):1194-8.
1987: Catherine Rivier; Wylie Vale; Jean Rivier
Studies of the inhibin family of hormones: a review.
Hormone research 1987;28(2-4):104-18.
1987: Catherine Rivier; Jean Rivier; Wylie Vale
Inhibin: measurement and role in the rat.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1987;14(4):273-6.